PASSARIELLO, MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.708
NA - Nord America 1.269
EU - Europa 1.189
SA - Sud America 200
AF - Africa 47
OC - Oceania 1
Totale 4.414
Nazione #
US - Stati Uniti d'America 1.211
SG - Singapore 658
RU - Federazione Russa 537
CN - Cina 362
IT - Italia 349
VN - Vietnam 345
BR - Brasile 149
HK - Hong Kong 145
DE - Germania 74
FR - Francia 60
NL - Olanda 53
IN - India 47
JP - Giappone 35
GB - Regno Unito 29
CA - Canada 28
BD - Bangladesh 26
KR - Corea 25
MX - Messico 22
FI - Finlandia 16
ZA - Sudafrica 16
CI - Costa d'Avorio 15
EC - Ecuador 14
AT - Austria 12
IQ - Iraq 12
PL - Polonia 12
AR - Argentina 11
PH - Filippine 9
PY - Paraguay 9
SE - Svezia 9
ES - Italia 7
ID - Indonesia 7
IE - Irlanda 5
PK - Pakistan 5
TR - Turchia 5
BE - Belgio 4
CL - Cile 4
CO - Colombia 4
LT - Lituania 4
MA - Marocco 4
CH - Svizzera 3
PE - Perù 3
SA - Arabia Saudita 3
TH - Thailandia 3
UA - Ucraina 3
VE - Venezuela 3
EG - Egitto 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
Totale 4.414
Città #
Singapore 326
San Jose 277
Naples 164
Hong Kong 143
Moscow 141
Ashburn 118
Beijing 114
Ho Chi Minh City 100
Hefei 94
Chandler 78
Santa Clara 72
Hanoi 60
Los Angeles 51
Amsterdam 49
The Dalles 44
Lauterbourg 33
Tokyo 27
New York 25
Napoli 24
Dallas 22
Munich 22
Boston 20
São Paulo 20
Pune 18
Seoul 18
Lawrence 17
Haiphong 16
Rome 16
Ercolano 14
Seattle 14
Redondo Beach 13
Da Nang 12
Frankfurt am Main 12
Buffalo 11
Orem 11
Atlanta 10
Capaccio 10
Des Moines 10
Kochi 10
Millbury 10
Shanghai 10
Falkenstein 9
Helsinki 9
Warsaw 9
Biên Hòa 8
Brooklyn 8
Düsseldorf 8
Hải Dương 8
Nuremberg 8
Toronto 8
Chicago 7
Council Bluffs 7
Houston 7
London 7
Mexico City 7
Thái Bình 7
Columbus 6
Denver 6
Quito 6
Wilmington 6
Acerra 5
Johannesburg 5
Milan 5
Vienna 5
Brussels 4
Can Tho 4
Cape Town 4
Chennai 4
Guangzhou 4
Lappeenranta 4
Marano di Napoli 4
Montreal 4
Nanjing 4
New Delhi 4
Ninh Bình 4
Phoenix 4
Poplar 4
Portsmouth 4
Salvador 4
Stockholm 4
Baghdad 3
Bexley 3
Bologna 3
Bắc Giang 3
Calgary 3
Campinas 3
Casavatore 3
Caserta 3
Ciudad del Este 3
Erbil 3
Guayaquil 3
Long Xuyen 3
Nha Trang 3
Pozzuoli 3
Queens 3
Quảng Ngãi 3
Rio de Janeiro 3
San Francisco 3
Shijiazhuang 3
Tianjin 3
Totale 2.541
Nome #
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 177
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 173
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics 170
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 169
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 164
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 159
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 148
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 146
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 146
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 145
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 143
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 142
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 136
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 134
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 132
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 132
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 131
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 129
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 129
Fusion proteins 128
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 128
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 124
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy 122
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 122
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo 121
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 118
HUMAN ANTI-FV ANTIBODY, THERAPEUTIC AND DIAGNOSTIC APPLICATIONS THEREOF 116
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies 113
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 113
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models 107
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 106
A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches 92
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 85
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy 78
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in Patients With Cancer 19
Totale 4.497
Categoria #
all - tutte 13.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 11 0
2021/2022145 0 4 1 1 1 4 16 9 10 21 41 37
2022/2023241 19 12 9 13 29 25 0 24 37 46 23 4
2023/2024234 10 28 52 21 9 39 10 25 0 2 23 15
2024/20251.273 48 33 23 32 32 111 112 76 66 153 508 79
2025/20262.495 267 198 253 212 397 118 333 104 327 180 106 0
Totale 4.497